Although the underlying mechanisms driving prostate carcinogenesis remain elusive, it is widely accepted that prostate cancer cell growth and survival is exquisitely dependent upon activation of the androgen receptor (AR) by androgens. This evidence concerns the gene AR and urogenital neoplasm.